UNBELIEVABLE: Is dexcom stock underperforming the nasdaq | History Defined

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap of $30.4 billion, the company specializes in continuous glucose monitoring (CGM) systems for diabetes management. Its innovative devices provide real-time glucose data, enabling users to track their glucose levels and trends without fingerstick calibration

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and DexCom fits this criterion perfectly, exceeding the mark. The company has established itself as a leader in CGM technology through a focus on innovation, user-friendly design, and integration with digital health platforms.